After two years, Cell Bio 2022 will return as an in-person meeting December 3-7, 2022, in Washington, DC. We are excited to make it possible for colleagues to reconnect face-to-face, while keeping health and safety paramount. We understand flexibility is also important. In addition to our in-person meeting, limited content will be available on-demand for purchase after the meeting so that all scientists can access the cutting-edge cell biology research that was presented during the in-person meeting.

Stem cells are moving toward the clinic as cellular therapeutics in several indications and are being tested in clinical trials in others. They are also employed to advantage in the discovery of novel therapeutics in several modalities, including physiologically relevant toxicity and drug screening platforms, and lend themselves to other treatment modalities, including gene therapy, and personalized precision medicine. The goal of this Cell Symposium is to bring together clinicians, academic researchers, and industry and regulatory stakeholders to discuss advances in the field and to champion new ideas to overcome the current challenges across the clinical and translational spectrum of stem–cell-based research and therapy.